Polymeric Micelles for siRNA Delivery - RNA Interference from Biology to Therapeutics - page 178

27. Gref R, Luck M, Quellec P, Marchand M, Dellacherie E, Harnisch S, Blunk T, Muller RH
(2000) 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG):
influences of the corona (PEG chain length and surface density) and of the core composition
on phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerfaces
18:301-313
28. Harada A, Kataoka K (1995) Formation of polyion complex micelles in aqueous milieu from
a pair of oppositely-charged block copolymers with poly(ethylene glycol) segments.
Macromolecules 28:5294-5299
29. Yokoyama M, Inoue S, Kataoka K, Yui N, Okano T, Sakurai Y (1989) Molecular design for
missile drug-synthesis of adriamycin conjugated with immunoglobulin-G using poly(ethylene
glycol)-block-poly (aspartic acid) as intermediate carrier. Makromol Chem 190:2041-2054
30. Kataoka K, Ishihara A, Harada A, Miyazaki H (1998) Effect of the secondary structure of
poly(L-lysine) segments on the micellization in aqueous milieu of poly (ethylene glycol)-
poly(L-lysine) block copolymer partially substituted with a hydrocinnamoyl group at the
Nepsilon-position. Macromolecules 31:6071-6076
31. Oishi M, Nagasaki Y, Itaka K, Nishiyama N, Kataoka K (2005) Lactosylated poly(ethylene
glycol)-siRNA conjugate through acid-labile beta-thiopropionate linkage to construct pH-
sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells. J
Am Chem Soc 127(6):1624-1625
32. Kataoka K, Harada A, Wakebayashi D, Nagasaki Y (1999) Polyion complex micelles with
reactive aldehyde groups on their surface from plasmid DNA and end functionalized charged
block copolymers. Macromolecules 32:6892-6894
33. Schiffelers RM, Ansari A, Xu J, Zhou Q, Tang Q, Storm G, Molema G, Lu PY, Scaria PV,
Woodle MC (2004) Cancer siRNA therapy by tumor selective delivery with ligand-targeted
sterically stabilized nanoparticle. Nucleic Acids Res 32(19):e149
34. Oba M, Fukushima S, Kanayama N, Aoyagi K, Nishiyama N, Koyama H, Kataoka K (2007)
Cyclic RGD peptide-conjugated polyplex micelles as targetable gene delivery system directed
to cells possessing a v b 3 and a v b 5 integrins. Bioconjug Chem 18:1415-1423
35. Davis ME (2009) The fi rst targeted delivery of siRNA in humans via a self-assembling, cyclo-
dextrin polymer-based nanoparticle: from concept to clinic. Mol Pharm 6(3):659-668
36. Davis ME, Zuckerman JE, Choi CH, Seligson D, Tolcher A, Alabi CA, Yen Y, Heidel JD,
Ribas A (2010) Evidence of RNAi in humans from systemically administered siRNA via tar-
geted nanoparticles. Nature 464(7291):1067-1070
37. Park K, Lee MY, Kim KS, Hahn SK (2010) Target specific tumor treatment by VEGF siRNA
complexed with reducible polyethyleneimine-hyaluronic acid conjugate. Biomaterials
31:5258-5265
38. Nagasaki Y, Yasugi K, Yamamoto Y, Harada A, Kataoka K (2001) Sugar-installed block copo-
lymer micelles: their preparation and specific interaction with lectin molecules.
Biomacromolecules 2:1067-1070
39. Bae Y, Jang W-D, Nishiyama N, Fukushima S, Kataoka K (2005) Multifunctional polymeric
micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties
for active intracellular drug delivery. Mol Biosyst 1:242-250
40. Ringsdorf H (1975) Structure and properties of pharmacologically active polymers. J Polym
Sci Symp 51:135-153
41. Lloyd JB, Duncan R, Kopecek J (1986) Synthetic polymers as carriers for chemotherapeutic
agents. Biochem Soc Trans 14(2):391-392
42. Yokoyama M, Inoue S, Kataoka K, Yui N, Sakurai Y (1987) Preparation of adriamycin-conju-
gated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Makromol Chem 8:431-435
43. Plestil J, Baldrian J (1973) Small-angle X-ray scattering of the block copolymer polystyrene/
polybutadiene/polystyrene in ethyl methyl ketone. Makromol Chem 174:183-191
44. Kabanov AV, Chekhonin VP, Alakhov VY, Batrakova EV, Lebedev AS, Melik-Nubarov NS,
Arzhakov SA, Levashov AV, Morozov GV, Severin ES, Kabanov VA (1989) The neuroleptic
activity of haloperidol increases after its solubilization in surfactant micelles. FEBS Lett
258:343-345